HeartGenetics was present at “9ªs Jornadas de Prevenção do Risco Cardiovascular para Medicina Familiar”, a medical meeting on the prevention of cardiovascular risk that took place in Albufeira (Algarve) on July 19th-20th . Ana Teresa Freitas, CEO, presented HeartGenetics’ innovative methodology to support the genetic diagnosis of cardiovascular diseases. New products, namely the cardiovascular IVDD genetic panels have also been presented. HeartGenetics was congratulated by the importance of its new genetic tests in several areas, e.g.: Obstetrics, Cardiology and Pharmacogenomics, and by the cost-effectiveness of its products. HeartGenetics took this opportunity to show that genetic testing is already a highly accurate tool to support cardiovascular diagnosis and that HeartGenetics technological approach presents an accuracy of 99%.
Isabel Gaspar, member of HeartGenetics advisory board, authored an article about Familial Hypercholesterolemia in the context of this meeting, published in the Jornal Médico (20th July).
Read it below [in Portuguese].
This article was published on June 24, 2015.